Pages that link to "Q37354899"
Jump to navigation
Jump to search
The following pages link to PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. (Q37354899):
Displaying 29 items.
- Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS? (Q26774826) (← links)
- Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders (Q26997105) (← links)
- Both PD-1 ligands protect the kidney from ischemia reperfusion injury (Q30301290) (← links)
- Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke. (Q34024724) (← links)
- Antigen-specific immune reactions to ischemic stroke. (Q34171339) (← links)
- Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy (Q34242088) (← links)
- Splenectomy reduces infarct volume and neuroinflammation in male but not female mice in experimental stroke (Q34980295) (← links)
- Functional role of regulatory lymphocytes in stroke: facts and controversies (Q35554595) (← links)
- Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153. (Q35611631) (← links)
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T (Q35798161) (← links)
- Differential induction of PD-1/PD-L1 in Neuroimmune cells by drug of abuse. (Q35997650) (← links)
- PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation (Q36109112) (← links)
- Sex differences and the role of PPAR alpha in experimental stroke (Q36892933) (← links)
- Sex differences in the immune response to experimental stroke: Implications for translational research (Q37432327) (← links)
- Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke (Q37612249) (← links)
- Roles of programmed death protein 1/programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats: selective modulation of microglia polarization to anti-inflammatory phenotype (Q37642998) (← links)
- PD-1 modulates steady-state and infection-induced IL-10 production in vivo (Q38285933) (← links)
- Regulatory T Cells in Post-stroke Immune Homeostasis (Q38794156) (← links)
- Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats. (Q39231546) (← links)
- Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice (Q42002738) (← links)
- B7-H1 Influences the Accumulation of Virus-Specific Tissue Resident Memory T Cells in the Central Nervous System. (Q44323857) (← links)
- Protective effect of autophagy in neural ischemia and hypoxia: Negative regulation of the Wnt/β-catenin pathway (Q47149052) (← links)
- Brain-immune interactions in perinatal hypoxic-ischemic brain injury. (Q47624437) (← links)
- Hypoxia induces microglia autophagy and neural inflammation injury in focal cerebral ischemia model (Q48336830) (← links)
- The human blood DNA methylome identifies crucial role of β-catenin in the pathogenesis of Kawasaki disease. (Q55504414) (← links)
- Association Between Programed Cell Death-1 and CD4 T Cell Alterations in Different Phases of Ischemic Stroke Patients. (Q64926508) (← links)
- Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets (Q89575447) (← links)
- Sex differences in the therapeutic effects of anti-PDL2 neutralizing antibody on stroke (Q92608469) (← links)
- LRP-1 functionalized polymersomes enhance the efficacy of carnosine in experimental stroke (Q92783309) (← links)